Clinical Applications
Claire Booth, MBBS MSc PhD FRCPCH (she/her/hers)
Infection, Immunity and Inflammation Department
UCL Great Ormond Street Institute of Child Health, United Kingdom
Alice Del Vecchio
Molecular Medicine
Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Italy
Rosario Isasi, JD MPH (she/her/hers)
Human Genetics
University of Miami, United States
Mo Li, PhD
Bioscience
King Abdullah University of Science and Technology (KAUST), Saudi Arabia
Sarah Saietz, MSc, BSc (she/her/hers)
Department of Clinical Science, Intervention and Technology (CLINTEC)
Karolinska Institutet, Sweden
This session delves into groundbreaking advancements in gene therapies, focusing on the hematopoietic stem cell (HSC) system. Topics include gene addition and editing techniques, including CRISPR/Cas9 and prime editing, and their applications in treating genetic diseases affecting the blood, central nervous system (CNS), skeletal systems, and more. This session will also cover emerging in vivo gene therapy strategies targeting HSCs and immune cells, as well as the regulatory, accessibility, and economic challenges associated with these advanced therapies.
Presenting Author: Rosario Isasi, JD MPH (she/her/hers) – University of Miami
Presenting Author: Sarah Kieler Saietz, MSc, BSc (she/her/hers) – Karolinska Institutet
Presenting Author: Mo Li, PhD – King Abdullah University of Science and Technology (KAUST)
Presenting Author: Alice Del Vecchio – Istituto di Ricerche Farmacologiche Mario Negri IRCCS
Concurrent Speaker: Claire Booth, MBBS MSc PhD FRCPCH (she/her/hers) – UCL Great Ormond Street Institute of Child Health